Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can chatting about End-of-Life care in groups make a difference?

NCT ID NCT05421728

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether group visits in primary care can help adults aged 70 and older complete advance care planning documents, like living wills. About 516 participants will either join two 2-hour group discussions or receive mailed resources. The goal is to see if the group approach leads to more people having their healthcare wishes on file.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ENACT group visit (behavioral intervention)
What this could lead to
If successful, this could show that group discussions in primary care are an effective way to help older adults document their healthcare wishes.
What could go wrong
This is a behavioral study, not a medical treatment. The outcome depends on patient participation and may not apply to all populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

516 people

The number who actually took part.

Started

Jul 2022

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Patient Participants: Inclusion Criteria: * 70 or older * At least one clinic visit in past year * No advanced care planning (ACP) document in electronic health record based on a clinic-level, population-based report * Preferred language English for UCHealth clinics or preferred language English or Spanish for Denver Health clinic Exclusion Criteria: * Inability to demonstrate informed consent * Does not have ready access to a telephone * Inability to travel to clinic * Moving out of area in 6 months * Inability to participate in group visits due to hearing impairment as determined by clinic and/or study staff * A household member (same address) is already enrolled Caregivers Inclusion Criteria: * Age 18 and older * Preferred language English for UCHealth clinics or preferred language English or Spanish for Denver Health clinic * Patient with potential cognitive impairment consented to participate in study Exclusion Criteria: * Does not have ready access to a telephone * Inability to travel to clinic * Moving out of area in 6 months * Inability to participate in group visits due to hearing impairment as determined by clinic and/or study staff Clinic Stakeholders Inclusion Criteria: * Work as a multidisciplinary team member at a participating primary care clinic in the study * English speaking as a preferred language * Invited to participate in interviews or focus groups after the ENACT Group Visits intervention Exclusion Criteria: \- Inability to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Advance care planning are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Denver Health Westside Clinic

    Denver, Colorado, 80204, United States

  • UC Health AF Williams Family Medicine

    Denver, Colorado, 80238, United States

  • UC Health Boulder Family Medicine

    Boulder, Colorado, 80303, United States

  • UC Health Lone Tree Primary Care

    Lonetree, Colorado, 80124, United States

  • UC Health Lone Tree Seniors

    Lone Tree, Colorado, 80124, United States

  • UC Health Lowry Internal Medicine

    Denver, Colorado, 80230, United States

  • UC Health Westminster Primary Care

    Westminster, Colorado, 80021, United States

  • UCHealth

    Aurora, Colorado, 80045, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.